Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Singapore: Novena makes acquisitions in Singapore and Taiwan

Singapore-based Novena Global Lifecare Group, one of Asia’s largest and fastest-growing integrated medical healthcare and aesthetic groups, has announced a number of acquisitions. It has bought four eye care centres in Singapore and a majority stake in Taiwan’s Hexin Group, the third largest healthcare screening provider in Taipei. Financial terms have not been disclosed.

In Singapore it has acquired Total EyeCare Center at Orchid Hotel and a branch in Jurong East with a client base of more than 25,000 patients; and the Specialist Eye & Eyelids Clinic at Novena and The Eye & Aesthetics Clinic in Suntec City.

“This investment is the first of several to come as we execute our vision to provide integrated and quality healthcare and medical aesthetic services at affordable prices to our patients in Singapore and the region,” said Nelson Loh, executive chairman and co-founder of Novena Global.

The acquisition of a majority stake in Hexin will allow Novena Global to manage and oversee healthcare screening services in some of the largest hospitals in Taipei, namely Taipei Medical University Hospital, Taoyuan General Hospital, China Medical University Hospital and Taipei Beitou Hospital.

Hexin Group was founded in 2007 and works with hospitals in Taiwan to provide health monitoring services to corporate clients’ employees. Its key corporate accounts include the top MNC companies in financial services, electronics, biotech, hospitality, consumer and retail sectors. In all, Hexin provides health screening for over 200,000 corporate employees.

In Taiwan, Novena Global said that it also plans to develop predictive care through DNA testing with its partnership with another Taiwanese company, Health GeneTech. It will work with leading universities and regional labs in Taiwan, Korea, India and Hong Kong to develop an extensive database on Asian genetics for predictive developmental and healthcare management.

It is also in talks with what it calls “a Taiwan leading healthcare group” to develop a maternity care centre as it sees a growing market for post-natal care in Singapore.

In late July Novena Global announced that it plans to raise US$150 million through a listing on the Taiwan Stock Exchange to expand regionally in North Asia both organically and through acquisitions.

Posted on: 16/11/2017 UTC+08:00


News

Trendlines Medical Singapore, a subsidiary of SGX-listed Israeli medical and agricultural technology incubator Trendlines, has entered into a memorandum of understanding with Accelerate Technologies for both parties to collaborate and explore potential joint research and development initiatives in several medical technology areas.
Leading healthcare company, TIENS Group, has announced their global expansion into the new retail market with the opening of a new flagship TIENS Experience Store in China. Located in the TIENS International Health Industrial Park, the new store features a combination of online and offline consumer experiences through a technology-enhanced approach to new retail business and marketing.
Bumrungrad Hospital, Thailand’s second-largest listed hospital operator, continues to expand its investment. It will take a 30% stake in Singapore’s iDoctor for US$3 million and will invest Bt270 million (US$8.2 million) in a wellness center clinic under the project name Project Beta of Vitallife.
Ping An Good Doctor, UMP Healthcare and Zheng He Health and Medical Resources have announced their strategic cooperation. The three parties will make full use of their respective advantages and resources to jointly build an online and offline family doctor services network and realise the shared vision of "providing each family with a trusted family doctor". This cooperation also aims to help the government to achieve the goal of promoting and developing family doctor services across China.
HuiyiHuiying (HY), a leading medical imaging artificial intelligence company in China, has closed a strategic investment led by Intel Capital with participation of Beijing Singularity Power Investment Fund (SPC), marking the first investments by the firms in the medical AI sector in China. HY will use the funding proceeds to support its business development, product innovation and talent recruitment initiatives.
Australian hearing implant manufacturer Cochlear and GN, the global leader in intelligent audio solutions, have signed a new agreement to expand their Smart Hearing Alliance collaboration significantly.
China's leading clinical genomics testing company, Berry Genomics, and Prenetics – the leading consumer digital health and genetics testing company in southeast Asia and Europe – will establish a joint venture company that will deliver transformative consumer digital health and genetics testing services in mainland China.
Ping An Good Doctor (PAGD) has announced that the first commercially operational unmanned clinic in China, which it researched and developed, "One-minute Clinics" has been formally revealed in a scenic area in Wuzhen. It will provide a high-speed, convenient, one-stop shop for medical and healthcare services for nearby residents, visitors to the scenic area and guests of the 2018 World Internet Conference.



Analysis

The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.
For too many companies, a stock market flotation is the be all and end all. Chief executives have spent months on roadshows, locked up with bankers and lawyers. Understandably they think that they can now rest on their laurels.
Today is the launch of Asia Pacific’s first Life Sciences Centre of Excellence. It is part of global management consulting firm LEK Consulting’s Healthcare Insights Centre and aims to drive thought leadership and innovation to elevate the life sciences ecosystem in Singapore and the region.
Dementia remains one of the biggest chronic medical issues to face families. A determination to treat the illness is a challenge that Charles Stacey, president and CEO of Singapore-based Cerecin, has grasped with both hands.
Abrar Mir is that rare thing in the healthcare sector: a voice of reason. It notable that when he speaks at conferences, the chatter outside the auditorium diminishes and seats suddenly become hard to find. Part of this is thanks to his position as managing partner of Singapore-based private equity fund Quadria Healthcare, which he co-founded in 2012. But as much of it is due to his quiet authority and passion, as it is to the US$1.5 billion he has under management across the Asia Pacific region.
SOHO Global Health was founded in 1946 in Jakarta by Tan Tjhoen Lim as an injectables-focused pharmaceutical company. Today it is one of the largest pharmaceutical manufacturing and distribution businesses in Indonesia with a network that covers more than 80% of the hospitals and 90% of the pharmacies in the country.
Anupa Naik speaks nineteen to the dozen. The chief executive of Symple Wellness, a healthcare company set up in Singapore in July last year as an offshoot of the family office AJ Capital, has barely stood still since then, and shows no sign of stopping any time soon.
After listing on the Hong Kong Stock Exchange at the beginning of May, Ping An Healthcare and Technology, formerly known as Good Doctor, shows no sign of slowing down.
my images

Podcasts

HealthInvestor Asia twitter feed